Encompass Health Corporation
EHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12,765,510 | $12,336,578 | $10,178,640 | $9,235,000 |
| - Cash | $48,700 | $99,100 | $95,800 | $85,400 |
| + Debt | $267,700 | $2,685,700 | $2,702,800 | $354,600 |
| Enterprise Value | $12,984,510 | $14,923,178 | $12,785,640 | $9,504,200 |
| Revenue | $1,477,500 | $1,457,700 | $1,455,400 | $1,405,000 |
| % Growth | 1.4% | 0.2% | 3.6% | – |
| Gross Profit | $692,700 | $626,900 | $630,900 | $585,900 |
| % Margin | 46.9% | 43% | 43.3% | 41.7% |
| EBITDA | $333,100 | $347,100 | $349,600 | $312,400 |
| % Margin | 22.5% | 23.8% | 24% | 22.2% |
| Net Income | $126,500 | $142,100 | $151,500 | $120,900 |
| % Margin | 8.6% | 9.7% | 10.4% | 8.6% |
| EPS Diluted | 1.24 | 1.39 | 1.48 | 1.18 |
| % Growth | -10.8% | -6.1% | 25.4% | – |
| Operating Cash Flow | $270,800 | $270,200 | $288,600 | $278,800 |
| Capital Expenditures | -$187,100 | -$156,900 | -$163,100 | -$198,700 |
| Free Cash Flow | $83,700 | $113,300 | $125,500 | $80,100 |